Your browser is no longer supported. Please, upgrade your browser.
ATRS Antares Pharma, Inc. monthly Stock Chart
ATRS [NASD]
Antares Pharma, Inc.
Index- P/E94.55 EPS (ttm)0.03 Insider Own2.80% Shs Outstand165.70M Perf Week6.48%
Market Cap505.00M Forward P/E12.48 EPS next Y0.25 Insider Trans0.36% Shs Float154.20M Perf Month11.83%
Income5.60M PEG- EPS next Q0.03 Inst Own43.10% Short Float2.66% Perf Quarter13.45%
Sales137.60M P/S3.67 EPS this Y69.90% Inst Trans-5.70% Short Ratio4.72 Perf Half Y11.03%
Book/sh0.35 P/B8.91 EPS next Y296.83% ROA4.20% Target Price- Perf Year-34.59%
Cash/sh0.32 P/C9.79 EPS next 5Y- ROE10.60% 52W Range1.60 - 5.13 Perf YTD-33.62%
Dividend- P/FCF82.79 EPS past 5Y45.90% ROI1.00% 52W High-39.57% Beta1.37
Dividend %- Quick Ratio2.40 Sales past 5Y36.10% Gross Margin60.30% 52W Low93.75% ATR0.14
Employees178 Current Ratio2.90 Sales Q/Q14.10% Oper. Margin6.70% RSI (14)58.86 Volatility4.81% 4.53%
OptionableYes Debt/Eq0.00 EPS Q/Q193.90% Profit Margin4.00% Rel Volume1.37 Prev Close3.12
ShortableYes LT Debt/Eq0.71 EarningsNov 05 BMO Payout0.00% Avg Volume869.31K Price3.10
Recom1.50 SMA205.67% SMA504.63% SMA2009.53% Volume558,065 Change-0.64%
Oct-23-17Reiterated H.C. Wainwright Buy $5 → $3.50
Jun-23-17Initiated H.C. Wainwright Buy $5
Apr-21-17Initiated Raymond James Strong Buy
May-28-15Initiated Jefferies Buy $5
May-18-15Initiated Piper Jaffray Overweight $3.50
Aug-08-13Reiterated Ladenburg Thalmann Buy $5 → $5.75
Jun-21-13Resumed Oppenheimer Outperform $6
Nov-23-20 04:05PM  
Nov-10-20 04:30PM  
Nov-05-20 10:31PM  
10:05AM  
07:00AM  
06:14AM  
Oct-29-20 12:35PM  
Oct-22-20 08:30AM  
Oct-12-20 06:28PM  
Oct-06-20 07:39AM  
Oct-01-20 08:46AM  
Sep-08-20 08:00AM  
Sep-06-20 10:14AM  
Aug-10-20 07:00AM  
Aug-07-20 09:17AM  
Aug-06-20 07:00AM  
Aug-03-20 10:55AM  
07:00AM  
Jul-30-20 07:00AM  
Jul-21-20 07:00AM  
Jul-20-20 07:00AM  
Jun-24-20 09:39AM  
Jun-22-20 11:48AM  
Jun-11-20 07:00AM  
May-28-20 07:07AM  
May-27-20 07:00AM  
May-26-20 12:36AM  
May-05-20 09:30PM  
12:24PM  
07:00AM  
Apr-28-20 07:00AM  
Mar-22-20 06:13AM  
Mar-03-20 07:00AM  
Mar-01-20 09:20AM  
Feb-26-20 07:00AM  
Feb-25-20 07:00AM  
Jan-27-20 07:00AM  
Jan-16-20 05:59AM  
Dec-14-19 05:20PM  
Dec-10-19 07:00AM  
Dec-06-19 07:00AM  
Dec-02-19 09:49AM  
Nov-27-19 05:51PM  
Nov-20-19 07:25AM  
Nov-19-19 07:00AM  
01:00AM  
Nov-13-19 07:00AM  
Nov-09-19 08:03PM  
Nov-05-19 07:00AM  
Nov-01-19 11:49AM  
Oct-31-19 07:00AM  
Oct-29-19 07:00AM  
Oct-24-19 07:00AM  
Oct-17-19 06:55AM  
Sep-17-19 07:00AM  
Sep-11-19 11:50AM  
Aug-20-19 08:09AM  
Aug-14-19 02:14PM  
Aug-06-19 05:23PM  
03:00PM  
07:00AM  
Jul-30-19 07:00AM  
Jun-27-19 07:00AM  
Jun-26-19 02:08PM  
Jun-11-19 07:00AM  
Jun-06-19 11:45AM  
May-30-19 07:00AM  
May-16-19 05:00PM  
May-13-19 06:14AM  
May-09-19 02:23PM  
May-02-19 01:49PM  
09:01AM  
07:00AM  
Apr-18-19 07:00AM  
Apr-02-19 09:43AM  
Apr-01-19 07:30AM  
Mar-28-19 07:30AM  
Mar-15-19 03:43PM  
Mar-12-19 06:48PM  
Mar-11-19 10:35AM  
Mar-06-19 07:00AM  
Mar-04-19 07:00AM  
Feb-28-19 12:31PM  
07:00AM  
Feb-27-19 07:00AM  
Feb-25-19 05:00PM  
Jan-20-19 09:49AM  
Dec-13-18 10:32AM  
07:00AM  
Dec-10-18 09:45AM  
Dec-08-18 07:50PM  
Dec-05-18 05:09PM  
Dec-03-18 08:15AM  
Nov-29-18 07:00AM  
Nov-28-18 08:39AM  
Nov-27-18 01:47PM  
10:36AM  
Nov-26-18 10:45AM  
07:30AM  
Nov-19-18 11:51AM  
Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. The company's injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; XYOSTED for the treatment of testosterone deficiency in adult males; Sumatriptan Injection USP for the acute treatment of migraine and cluster headache in adults. Its injection products also comprise Epinephrine Injection USP for treating Anaphylaxis; Makena auto injectors to reduce the risk of preterm birth in women pregnant with a single baby; ZOMAJET and Twin-Jector EZ II Needle-free Injectors to administer human growth hormone for patients with growth retardation. In addition, the company develops disposable pen injectors for diabetes and osteoporosis; and QuickShot auto injectors. It has strategic alliances with Teva Pharmaceutical Industries, Ltd., AMAG Pharmaceuticals, Inc., Idorsia Pharmaceuticals Ltd, and Pfizer Inc. The company was founded in 1978 and is headquartered in Ewing, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Powell Fred MExecutive Vice President & CFONov 12Buy2.8516,40046,740646,465Nov 16 07:04 AM
GUETH ANTONDirectorMay 13Option Exercise1.6072,487115,979399,236May 15 04:30 PM
SAMSON MARVINDirectorJan 10Option Exercise2.665614951,807Jan 14 06:07 PM
SAMSON MARVINDirectorJan 10Sale4.505625251,751Jan 14 06:07 PM
SAMSON MARVINDirectorJan 02Option Exercise2.1899,944218,141101,751Jan 06 06:06 PM
SAMSON MARVINDirectorJan 02Sale4.5999,944459,24251,751Jan 06 06:06 PM
SAMSON MARVINDirectorDec 23Option Exercise1.12150,000168,000201,751Dec 26 04:57 PM
SAMSON MARVINDirectorDec 23Sale4.71150,000706,50051,751Dec 26 04:57 PM
APPLE ROBERT FPresident & CEODec 10Option Exercise3.9658,524231,7551,964,415Dec 11 07:15 PM
APPLE ROBERT FPresident & CEODec 10Sale4.7658,524278,3581,905,891Dec 11 07:15 PM
APPLE ROBERT FPresident & CEODec 09Option Exercise2.08308,000640,3802,015,891Dec 11 07:15 PM
JACOB LEONARD SDirectorDec 09Option Exercise1.63160,000260,800377,563Dec 11 07:21 PM
GARRITY THOMAS JDirectorDec 09Option Exercise1.6380,000130,400234,186Dec 11 07:24 PM
GARRITY THOMAS JDirectorDec 09Sale4.5880,000366,472194,186Dec 11 07:24 PM
JACOB LEONARD SDirectorDec 09Sale4.63244,8141,133,145212,749Dec 11 07:21 PM
APPLE ROBERT FPresident & CEODec 09Sale4.62308,0001,424,4181,905,891Dec 11 07:15 PM